Imdol refers to isosorbide mononitrate extended-release tablets, which are used for the prevention of vasospastic and mixed angina pectoris as well as for the treatment of coronary heart disease.
Isosorbide Mononitrate Extended-Release Tablets are intended for the long-term treatment of coronary heart disease and also for the treatment of post-myocardial infarction as well as chronic heart failure, and are also used for the prevention of vasospastic and mixed angina pectoris, the dilatation of coronary arteries, and the effective relief of symptoms.
For isosorbide mononitrate extended-release tablets allergy, hypertrophic obstructive cardiomyopathy, restrictive cardiomyopathy, constrictive pericarditis, pericardial tamponade, cardiogenic shock, severe hypotension, increased intracranial pressure, and glaucoma people are strictly prohibited.
The drug needs to be used rationally under the guidance of a doctor and in combination with one’s own situation to avoid adverse reactions such as drop in blood pressure, nausea, vomiting, headache, dizziness, and so on.